Supply Issues Intersurgical Ltd Nasal Cannula FDC777 (ICN 2975)

Change:

• The supplier Intersurgical Ltd has informed us of a supply issue with its Nasal Cannula products.
• One product code is affected.
  • FDC777 – Nasal cannula Curved prongs and ear guards adult 2.1m tube.
• The supply issue is due to supplier manufacturing issues.
• Due to this ongoing supply issue the product is now being threshold managed as they are subject to Protect Demand Management.

Impact:

• FDC777 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue:
  • FDC073 – Nasal cannula with curved prongs and tubing adult
  • FDC635 – Nasal cannula with curved/flared prongs and tubing adult
  • FDD5829 – Long Term Nasal Cannula Adult
  • FDD5831 – Long Term Nasal Cannula Adult.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 7 July 2025.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.